GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr Lalchandani Labs Ltd (BOM:541299) » Definitions » EBITDA Margin %

Dr Lalchandani Labs (BOM:541299) EBITDA Margin % : 61.23% (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Dr Lalchandani Labs EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Dr Lalchandani Labs's EBITDA for the six months ended in Mar. 2024 was ₹12.76 Mil. Dr Lalchandani Labs's Revenue for the six months ended in Mar. 2024 was ₹20.83 Mil. Therefore, Dr Lalchandani Labs's EBITDA margin for the quarter that ended in Mar. 2024 was 61.23%.


Dr Lalchandani Labs EBITDA Margin % Historical Data

The historical data trend for Dr Lalchandani Labs's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Lalchandani Labs EBITDA Margin % Chart

Dr Lalchandani Labs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.36 21.48 21.47 1.95 33.79

Dr Lalchandani Labs Semi-Annual Data
Mar13 Mar14 Mar15 Mar16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.59 -7.10 9.45 12.82 61.23

Competitive Comparison of Dr Lalchandani Labs's EBITDA Margin %

For the Diagnostics & Research subindustry, Dr Lalchandani Labs's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Lalchandani Labs's EBITDA Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr Lalchandani Labs's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Dr Lalchandani Labs's EBITDA Margin % falls into.



Dr Lalchandani Labs EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Dr Lalchandani Labs's EBITDA Margin % for the fiscal year that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=16.253/48.094
=33.79 %

Dr Lalchandani Labs's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=12.757/20.833
=61.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dr Lalchandani Labs  (BOM:541299) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Dr Lalchandani Labs EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Dr Lalchandani Labs's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr Lalchandani Labs (BOM:541299) Business Description

Traded in Other Exchanges
N/A
Address
Greater Kailash, Part-1, M-20, Basement, South Delhi, New Delhi, IND, 110048
Dr Lalchandani Labs Ltd engages in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations. It also offers Immunoassay, Immuno-Histochemistry, Molecular Pathology, DNA, and Genetic Testing. The company operates in two segments B2B sales and B2C sales, out of which the majority is from B2C sales. Revenue is generated from the sale of services.

Dr Lalchandani Labs (BOM:541299) Headlines

No Headlines